Common use of Licenses or Permits Clause in Contracts

Licenses or Permits. The Company possesses all licenses, certificates, authorizations and permits issued by, and has made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) that are necessary for the ownership or lease of its properties or the conduct of its businesses as described in the General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”), except where any failures to possess or make the same would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company is in compliance with all such Governmental Permits and all such Governmental Permits are valid and in full force and effect, except where the failure to comply or the invalidity or failure to be in full force and effect would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has not received written notification of any revocation, adverse modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit, except where any such revocation, adverse modification, suspension, termination or invalidation (or proceedings related thereto) would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect, and the Company has no reason to believe that any such Governmental Permit will not be renewed, except where any such non-renewal would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Licenses or Permits. The Company possesses all licenses, certificates, authorizations and permits issued by, and has have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) that are necessary for the ownership or lease of its properties or the conduct of its businesses business as described in the General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”), ) except where any failures to possess or make the same would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company is in compliance with all such Governmental Permits and Permits; all such Governmental Permits are valid and in full force and effect, except where the failure to comply or the invalidity or failure to be in full force and effect would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. All such Governmental Permits are free and clear of any restriction or condition that are in addition to, or materially different from those normally applicable to similar licenses, certificates, authorizations and permits. The Company has not received written notification of any revocation, adverse modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental PermitPermit and no event has occurred that allows or results in, except where any such or after notice or lapse of time or both would allow or result in, revocation, adverse modification, suspension, termination or invalidation (or proceedings related theretothereto ) would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect, of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except where any such non-renewal would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Licenses or Permits. The Company and each of its subsidiaries possesses all required licenses, certificates, authorizations and permits issued by, and has registered as a medical device establishment with the U.S. Food and Drug Administration (“FDA”) and other governmental or regulatory authorities performing functions similar to those performed by the FDA and have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) that are necessary for the ownership or lease of its their respective properties or the conduct of its their respective businesses as described in the General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”), ) except where any failures to possess or make the same would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company is and its subsidiaries are in compliance with all such Governmental Permits Permits, including with all conditions and limitations on the commercial rights granted by such Governmental Permits; all such Governmental Permits are valid and in full force and effect, except where the failure to comply or the invalidity or failure to be in full force and effect would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Neither the Company nor any subsidiary has not received written notification of any revocation, adverse modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit, except where any such revocation, adverse modification, suspension, termination or invalidation (or proceedings related thereto) would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect, Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except where any such non-renewal would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Licenses or Permits. The Company and each of its subsidiaries possesses all required licenses, certificates, authorizations and permits issued by, and has registered as a medical device establishment with the U.S. Food and Drug Administration (“FDA”) and other governmental or regulatory authorities performing functions similar to those performed by the FDA and have made all declarations and filings with, with the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) that are necessary for the ownership or lease of its their respective properties or the conduct of its their respective businesses as described in the General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”), ) except where any failures to possess or make the same would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company is and its subsidiaries are in compliance with all such Governmental Permits Permits, including with all conditions and limitations on the commercial rights granted by such Governmental Permits; all such Governmental Permits are valid and in full force and effect, except where the failure to comply or the invalidity or failure to be in full force and effect would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Neither the Company nor any subsidiary has not received written notification of any revocation, adverse modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental Permit, except where any such revocation, adverse modification, suspension, termination or invalidation (or proceedings related thereto) would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect, Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except where any such non-renewal would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Licenses or Permits. The Company possesses and each of its subsidiaries possess all licenses, certificates, authorizations and permits issued by, and has have made all declarations and filings with, the appropriate local, state, federal federal, supranational or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDAauthority) that are necessary for the ownership or lease of its their respective properties or the conduct of its their respective businesses as described in the General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”), ) except where any failures to possess or make the same would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company is and its subsidiaries are in compliance with all such Governmental Permits Permits, except where noncompliance would not reasonably be expected to have a Material Adverse Effect, and all such Governmental Permits are valid and in full force and effect, except where the failure to comply or the invalidity or failure to be in full force and effect would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Neither the Company nor any subsidiary has not received written or, to the Company’s knowledge, oral notification of any revocation, adverse modification, suspension, termination termination, limitation, restriction or invalidation (or proceedings related thereto) of any such Governmental Permit, except where any such revocation, adverse modification, suspension, termination or invalidation (or proceedings related thereto) would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect, Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed, except where any for such non-renewal revocations, modifications, suspensions, terminations, or invalidations which would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Licenses or Permits. The Company possesses all licenses, certificates, authorizations and permits issued by, and has have made all declarations and filings with, the appropriate local, state, federal or foreign governmental or regulatory agencies or bodies (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA) that which are necessary for the ownership or lease of its properties or the conduct of its businesses business as described in the General Disclosure Package and the Prospectus (collectively, the “Governmental Permits”), ) except where any failures to possess or make the same would notnot reasonably be expected to have, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company is in compliance with all such Governmental Permits Permits, except where the failure to be in compliance and effect would not reasonably be expected to have, singularly or in the aggregate, a Material Adverse Effect; all such Governmental Permits are valid and in full force and effect, except where the failure to comply or the invalidity validity or failure to be in full force and effect would notnot reasonably be expected to have, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has not received written notification of any revocation, adverse modification, suspension, termination or invalidation (or proceedings related thereto) of any such Governmental PermitPermit and, except where any such to the Company’s knowledge, no event has occurred that allows or results in, or after notice or lapse of time or both would allow or result in, revocation, adverse modification, suspension, termination or invalidation (or proceedings related thereto) would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect, of any such Governmental Permit and the Company has no reason to believe that any such Governmental Permit will not be renewed; and the Company is a member in good standing of each Federal, state or foreign exchange, board of trade, clearing house or association and self-regulatory or similar organization, in each case as necessary to conduct its business as described in the General Disclosure Package and the Prospectus, except where any such non-renewal the failure to be in good standing and effect would notnot reasonably be expected to have, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect.